Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas	Disease Attributes, Disease Progression, Ewing sarcoma, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, Neoplasms, Fibrous Tissue, Pathologic Complete Response, Pathologic Processes, Pathological Conditions, Signs and Symptoms, angiosarcoma, bone disorder, bone sarcoma, chondrosarcoma, connective tissue neoplasm, histiocytoma, leiomyosarcoma, musculoskeletal system disorder, myomatous neoplasm, neoplasm, osteosarcoma, sarcoma, undifferentiated pleomorphic sarcoma, vascular cancer	Recruiting	Not applicable	2026-02-17		NCT04055220

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Centre Leon Berard	67

16 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
APHM - Hôpital Timone	Marseille	France	1
APHP Hôpital Cochin	Paris	France	2
Centre Hospitalier Régional de Strasbourg Hautepierre	Strasbourg	France	1
Centre Hospitalier Universitaire de Poitiers	Poitiers	France	7
Centre Hospitalier Universitaire de Saint-Etienne (CHUSE)	Saint-Etienne	France	1
Centre Léon Bérard	Lyon	France	77
Centre Oscar Lambret	Lille	France	73
Centre Paul Strauss - Strasbourg	Strasbourg	France	1
Hôpital Jean Minjoz	Besançon	France	2
ICL Alexis Vautrin	Vandœuvre-lès-Nancy	France	1
ICM Val d'Aurelle	Montpellier	France	19
ICO René Gauducheau	Saint-Herblain	France	2
Institut Bergonié	Bordeaux	France	53
Institut Curie	Paris	France	81
Institut Gustave Roussy	Villejuif	France	113
IUCT-Oncopole	Toulouse	France	3